Published in Biophys J on October 06, 2010
Designed protein mimics of the Ebola virus glycoprotein GP2 α-helical bundle: stability and pH effects. Protein Sci (2011) 1.02
Crystal structure of the Marburg virus GP2 core domain in its postfusion conformation. Biochemistry (2012) 0.98
Marburg virus glycoprotein GP2: pH-dependent stability of the ectodomain α-helical bundle. Biochemistry (2012) 0.97
Influence of a heptad repeat stutter on the pH-dependent conformational behavior of the central coiled-coil from influenza hemagglutinin HA2. Proteins (2014) 0.76
The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science (1998) 39.86
Dominant forces in protein folding. Biochemistry (1990) 15.34
A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science (1993) 10.16
Protein denaturation. C. Theoretical models for the mechanism of denaturation. Adv Protein Chem (1970) 6.90
Hydrogen bonding in globular proteins. Prog Biophys Mol Biol (1984) 6.58
The folding of an enzyme. I. Theory of protein engineering analysis of stability and pathway of protein folding. J Mol Biol (1992) 6.10
Mapping the transition state and pathway of protein folding by protein engineering. Nature (1989) 5.44
Redox-coupled crystal structural changes in bovine heart cytochrome c oxidase. Science (1998) 5.01
Energetics of protein structure. Adv Protein Chem (1995) 4.82
An orientation-dependent hydrogen bonding potential improves prediction of specificity and structure for proteins and protein-protein complexes. J Mol Biol (2003) 4.63
On the calculation of pKas in proteins. Proteins (1993) 3.70
A relationship between protein stability and protein function. Proc Natl Acad Sci U S A (1995) 3.44
Peptide 'Velcro': design of a heterodimeric coiled coil. Curr Biol (1993) 3.32
Measurement of interhelical electrostatic interactions in the GCN4 leucine zipper. Science (1995) 2.53
A thermodynamic scale for leucine zipper stability and dimerization specificity: e and g interhelical interactions. EMBO J (1994) 2.32
Midbody targeting of the ESCRT machinery by a noncanonical coiled coil in CEP55. Science (2008) 2.23
Buried polar residues and structural specificity in the GCN4 leucine zipper. Nat Struct Biol (1996) 2.06
Engineered metal binding sites map the heterogeneous folding landscape of a coiled coil. Nat Struct Biol (2001) 1.98
The energetics of ion-pair and hydrogen-bonding interactions in a helical peptide. Biochemistry (1993) 1.94
High apparent dielectric constant inside a protein reflects structural reorganization coupled to the ionization of an internal Asp. Biophys J (2006) 1.89
Secondary structure of a leucine zipper determined by nuclear magnetic resonance spectroscopy. Biochemistry (1990) 1.86
Protein ionizable groups: pK values and their contribution to protein stability and solubility. J Biol Chem (2009) 1.85
Probing the folding mechanism of a leucine zipper peptide by stopped-flow circular dichroism spectroscopy. Biochemistry (1995) 1.78
High tolerance for ionizable residues in the hydrophobic interior of proteins. Proc Natl Acad Sci U S A (2008) 1.78
Molecular structure of an aspartic proteinase zymogen, porcine pepsinogen, at 1.8 A resolution. Nature (1986) 1.74
Kinetic role of early intermediates in protein folding. Curr Opin Struct Biol (1997) 1.74
Buried polar residues in coiled-coil interfaces. Biochemistry (2001) 1.62
Protein stabilization by salt bridges: concepts, experimental approaches and clarification of some misunderstandings. J Mol Recognit (2004) 1.61
The role of helix formation in the folding of a fully alpha-helical coiled coil. Proteins (1996) 1.58
Movement of the position of the transition state in protein folding. Biochemistry (1995) 1.56
Transition state heterogeneity in GCN4 coiled coil folding studied by using multisite mutations and crosslinking. Proc Natl Acad Sci U S A (1999) 1.51
The role of position a in determining the stability and oligomerization state of alpha-helical coiled coils: 20 amino acid stability coefficients in the hydrophobic core of proteins. Protein Sci (1999) 1.45
A heterodimerizing leucine zipper coiled coil system for examining the specificity of a position interactions: amino acids I, V, L, N, A, and K. Biochemistry (2002) 1.44
CC+: a relational database of coiled-coil structures. Nucleic Acids Res (2008) 1.34
Contributions of a hydrogen bond/salt bridge network to the stability of secondary and tertiary structure in lambda repressor. Protein Sci (1994) 1.32
Very rapid, ionic strength-dependent association and folding of a heterodimeric leucine zipper. Biochemistry (1997) 1.28
Preformed secondary structure drives the association reaction of GCN4-p1, a model coiled-coil system. J Mol Biol (2000) 1.23
Coiled coils at the edge of configurational heterogeneity. Structural analyses of parallel and antiparallel homotetrameric coiled coils reveal configurational sensitivity to a single solvent-exposed amino acid substitution. Biochemistry (2006) 1.21
Extremely fast folding of a very stable leucine zipper with a strengthened hydrophobic core and lacking electrostatic interactions between helices. Biochemistry (1999) 1.19
Ion pairs significantly stabilize coiled-coils in the absence of electrolyte. J Mol Biol (1996) 1.13
Kinking the coiled coil--negatively charged residues at the coiled-coil interface. J Mol Biol (2006) 1.08
Structural clues to the mechanism of ion pumping in bacteriorhodopsin. Adv Protein Chem (2003) 1.07
Protein vivisection reveals elusive intermediates in folding. J Mol Biol (2010) 1.06
On the precision of experimentally determined protein folding rates and phi-values. Protein Sci (2006) 1.06
pH-induced folding of an apoptotic coiled coil. Protein Sci (2001) 1.02
Barrier-limited, microsecond folding of a stable protein measured with hydrogen exchange: Implications for downhill folding. Proc Natl Acad Sci U S A (2004) 1.00
Fast folding of a helical protein initiated by the collision of unstructured chains. Proc Natl Acad Sci U S A (2004) 1.00
A buried polar residue in the hydrophobic interface of the coiled-coil peptide, GCN4-p1, plays a thermodynamic, not a kinetic role in folding. J Mol Biol (2002) 0.99
Energetics of coiled coil folding: the nature of the transition states. Biochemistry (2001) 0.99
Electrostatic contributions to the stability of the GCN4 leucine zipper structure. J Mol Biol (2007) 0.97
Electrostatic interactions in leucine zippers: thermodynamic analysis of the contributions of Glu and His residues and the effect of mutating salt bridges. J Mol Biol (2003) 0.96
Non-linear rate-equilibrium free energy relationships and Hammond behavior in protein folding. Biophys Chem (2003) 0.96
Structure and function of retroviral proteases. Annu Rev Biophys Biophys Chem (1991) 0.96
Mapping the energy surface for the folding reaction of the coiled-coil peptide GCN4-p1. Biochemistry (2001) 0.94
Salt-bridges can stabilize but do not accelerate the folding of the homodimeric coiled-coil peptide GCN4-p1. J Mol Biol (2004) 0.93
Inverse electrostatic effect: electrostatic repulsion in the unfolded state stabilizes a leucine zipper. Biochemistry (2004) 0.91
Unique stabilizing interactions identified in the two-stranded alpha-helical coiled-coil: crystal structure of a cortexillin I/GCN4 hybrid coiled-coil peptide. Protein Sci (2003) 0.90
T-jump infrared study of the folding mechanism of coiled-coil GCN4-p1. Biophys J (2005) 0.90
Self-assembly of coiled-coil tetramers in the 1.40 A structure of a leucine-zipper mutant. Protein Sci (2006) 0.87
Contribution of hydrogen bonding to protein stability estimated from isotope effects. Biochemistry (2002) 0.86
Salt bridges destabilize a leucine zipper designed for maximized ion pairing between helices. Biochemistry (2002) 0.85
Ligand effects on the protein ensemble: unifying the descriptions of ligand binding, local conformational fluctuations, and protein stability. Methods Cell Biol (2008) 0.85
Truncation of a cross-linked GCN4-p1 coiled coil leads to ultrafast folding. Biochemistry (2006) 0.82
Modest membrane hydrogen bonds deliver rich results. Nat Chem Biol (2008) 0.80
Stabilization of a pH-sensitive apoptosis-linked coiled coil through single point mutations. Protein Sci (2003) 0.79
Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature (2010) 3.95
Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study. J Natl Cancer Inst (2007) 3.25
A push-pull mechanism for regulating integrin function. Proc Natl Acad Sci U S A (2005) 1.82
Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel. Biochemistry (2010) 1.73
Nature-inspired design of motif-specific antibody scaffolds. Nat Biotechnol (2013) 1.68
Ultrafast folding of alpha3D: a de novo designed three-helix bundle protein. Proc Natl Acad Sci U S A (2003) 1.57
The conformation of the pore region of the M2 proton channel depends on lipid bilayer environment. Protein Sci (2005) 1.52
De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications. Acc Chem Res (2010) 1.52
Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus. Biochemistry (2009) 1.47
Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol (2007) 1.40
Probing designability via a generalized model of helical bundle geometry. J Mol Biol (2010) 1.37
Design of a switchable eliminase. Proc Natl Acad Sci U S A (2011) 1.34
Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Proc Natl Acad Sci U S A (2013) 1.34
Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trial. J Thorac Oncol (2012) 1.31
De novo design of a single-chain diphenylporphyrin metalloprotein. J Am Chem Soc (2007) 1.28
VeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumab. Lung Cancer (2009) 1.24
Early kinetic intermediate in the folding of acyl-CoA binding protein detected by fluorescence labeling and ultrarapid mixing. Proc Natl Acad Sci U S A (2002) 1.22
NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106-126. Proc Natl Acad Sci U S A (2003) 1.22
Identification of the pore-lining residues of the BM2 ion channel protein of influenza B virus. J Biol Chem (2008) 1.20
An atomic environment potential for use in protein structure prediction. J Mol Biol (2005) 1.19
Genetic and proteomic features associated with survival after treatment with erlotinib in first-line therapy of non-small cell lung cancer in Eastern Cooperative Oncology Group 3503. J Thorac Oncol (2010) 1.17
De novo design of a redox-active minimal rubredoxin mimic. J Am Chem Soc (2005) 1.16
Structural characterization of an equilibrium unfolding intermediate in cytochrome c. J Mol Biol (2006) 1.16
Early events during folding of wild-type staphylococcal nuclease and a single-tryptophan variant studied by ultrarapid mixing. J Mol Biol (2004) 1.15
Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients. Cancer Epidemiol Biomarkers Prev (2010) 1.13
De novo design and molecular assembly of a transmembrane diporphyrin-binding protein complex. J Am Chem Soc (2010) 1.11
Knowledge-based potential for positioning membrane-associated structures and assessing residue-specific energetic contributions. Structure (2012) 1.10
Quantitative matrix-assisted laser desorption/ionization mass spectrometry. Brief Funct Genomic Proteomic (2008) 1.09
Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments. J Am Chem Soc (2006) 1.09
Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane. J Virol (2012) 1.08
Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS. J Proteome Res (2008) 1.05
Computationally designed peptide inhibitors of protein-protein interactions in membranes. Biochemistry (2008) 1.05
Internal friction controls the speed of protein folding from a compact configuration. Biochemistry (2004) 1.05
Probing Membrane Insertion Activity of Antimicrobial Polymers via Coarse-grain Molecular Dynamics. J Chem Theory Comput (2006) 1.02
Activation of platelet alphaIIbbeta3 by an exogenous peptide corresponding to the transmembrane domain of alphaIIb. J Biol Chem (2006) 1.02
Kinetics of loop formation and breakage in the denatured state of iso-1-cytochrome c. J Mol Biol (2005) 1.02
A pH-dependent conformational ensemble mediates proton transport through the influenza A/M2 protein. Biochemistry (2010) 1.01
Parallel pathways in cytochrome c(551) folding. J Mol Biol (2003) 1.00
Early formation of a beta hairpin during folding of staphylococcal nuclease H124L as detected by pulsed hydrogen exchange. Protein Sci (2002) 1.00
Association of a model transmembrane peptide containing gly in a heptad sequence motif. Biophys J (2004) 0.98
Computational design of a self-assembling β-peptide oligomer. Org Lett (2010) 0.98
Role of the conformational rigidity in the design of biomimetic antimicrobial compounds. Angew Chem Int Ed Engl (2010) 0.98
Mapping of POP1-binding site on pyrin domain of ASC. J Biol Chem (2008) 0.97
Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation. Proc Natl Acad Sci U S A (2007) 0.97
Changes in plasma mass-spectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitors. J Thorac Oncol (2012) 0.97
Multiple Proton Confinement in the M2 Channel from the Influenza A Virus. J Phys Chem C Nanomater Interfaces (2010) 0.96
Polar networks control oligomeric assembly in membranes. J Am Chem Soc (2006) 0.96
Selective incorporation of nitrile-based infrared probes into proteins via cysteine alkylation. Biochemistry (2010) 0.95
A cytochrome c mutant with high electron transfer and antioxidant activities but devoid of apoptogenic effect. Biochem J (2002) 0.95
Rapid intrachain binding of histidine-26 and histidine-33 to heme in unfolded ferrocytochrome C. Biochemistry (2002) 0.95
Retroviral integrases promote fraying of viral DNA ends. J Biol Chem (2011) 0.93
Length Dependent Helix-Coil Transition Kinetics of Nine Alanine-Based Peptides. J Phys Chem B (2004) 0.93
Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller. Blood (2008) 0.92
Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus. ACS Med Chem Lett (2011) 0.92
Determination of the physiological dimer interface of the PhoQ sensor domain. J Mol Biol (2008) 0.92
Inhibition of integrin α2β1 ameliorates glomerular injury. J Am Soc Nephrol (2012) 0.92
VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer (2012) 0.92
Volatile anesthetic modulation of oligomerization equilibria in a hexameric model peptide. FEBS Lett (2004) 0.90
Autoinhibitory interactions between the PDZ2 and C-terminal domains in the scaffolding protein NHERF1. Structure (2009) 0.90
Investigation of an unnatural amino acid for use as a resonance Raman probe: Detection limits, solvent and temperature dependence of the νC≡N band of 4-cyanophenylalanine. J Raman Spectrosc (2008) 0.89
Dimer dissociation and unfolding mechanism of coagulation factor XI apple 4 domain: spectroscopic and mutational analysis. J Mol Biol (2006) 0.88
Folding kinetics of staphylococcal nuclease studied by tryptophan engineering and rapid mixing methods. J Mol Biol (2007) 0.88
The structure of a designed diiron(III) protein: implications for cofactor stabilization and catalysis. Angew Chem Int Ed Engl (2006) 0.88
Spectroscopic definition of the biferrous and biferric sites in de novo designed four-helix bundle DFsc peptides: implications for O2 reactivity of binuclear non-heme iron enzymes. Biochemistry (2009) 0.87
Controlling the conformation of arylamides: computational studies of intramolecular hydrogen bonds between amides and ethers or thioethers. Chemistry (2004) 0.87
Intrinsic disorder and oligomerization of the hepatitis delta virus antigen. Virology (2010) 0.87
Effects of heme on the structure of the denatured state and folding kinetics of cytochrome b562. J Mol Biol (2004) 0.87
Microsecond folding dynamics of apomyoglobin at acidic pH. J Phys Chem B (2012) 0.87
Ultrarapid mixing experiments shed new light on the characteristics of the initial conformational ensemble during the folding of ribonuclease A. Proc Natl Acad Sci U S A (2004) 0.87
Characterization of a membrane protein folding motif, the Ser zipper, using designed peptides. J Mol Biol (2006) 0.86
Arylamide derivatives as peptidomimetic inhibitors of calmodulin. Org Lett (2006) 0.85
Exploring Histidine Conformations in the M2 Channel Lumen of the Influenza A Virus at Neutral pH via Molecular Simulations. J Phys Chem Lett (2013) 0.85
Metal-binding dependent disruption of membranes by designed helices. J Am Chem Soc (2009) 0.84
Specificity for homooligomer versus heterooligomer formation in integrin transmembrane helices. J Mol Biol (2010) 0.84
Structure, stability, and function of hDim1 investigated by NMR, circular dichroism, and mutational analysis. Biochemistry (2003) 0.83
A single mutation in a regulatory protein produces evolvable allosterically regulated catalyst of nonnatural reaction. Angew Chem Int Ed Engl (2013) 0.83
Conformational equilibration time of unfolded protein chains and the folding speed limit. Biochemistry (2007) 0.82
Simulated evolution of emergent chiral structures in polyalanine. J Am Chem Soc (2004) 0.82
Mapping the epitope of an inhibitory monoclonal antibody to the C-terminal DNA-binding domain of HIV-1 integrase. J Biol Chem (2002) 0.82
Adhesion of MC3T3-E1 cells to RGD peptides of different flanking residues: detachment strength and correlation with long-term cellular function. J Biomed Mater Res A (2007) 0.82
Microsecond unfolding kinetics of sheep prion protein reveals an intermediate that correlates with susceptibility to classical scrapie. Biophys J (2011) 0.82
Folding mechanism of reduced Cytochrome c: equilibrium and kinetic properties in the presence of carbon monoxide. J Mol Biol (2008) 0.81
X-ray structure of a water-soluble analog of the membrane protein phospholamban: sequence determinants defining the topology of tetrameric and pentameric coiled coils. J Mol Biol (2005) 0.80
Modest membrane hydrogen bonds deliver rich results. Nat Chem Biol (2008) 0.80
Ultrafast hydrogen exchange reveals specific structural events during the initial stages of folding of cytochrome c. J Am Chem Soc (2013) 0.79
De novo design of self-assembling foldamers that inhibit heparin-protein interactions. ACS Chem Biol (2014) 0.79
Nonuniform chain collapse during early stages of staphylococcal nuclease folding detected by fluorescence resonance energy transfer and ultrarapid mixing methods. Protein Sci (2013) 0.78
In situ mass spectrometry of autoimmune liver diseases. Cell Mol Immunol (2011) 0.77
Nanosecond Dynamics of InfluenzaA/M2TM and an Amantadine Resistant Mutant Probed by Time-Dependent Red Shifts of a Native Tryptophan. Chem Phys (2013) 0.77
Competition between reversible aggregation and loop formation in denatured iso-1-cytochrome c. Biochemistry (2009) 0.76
Rotational orientation of monomers within a designed homo-oligomer transmembrane helical bundle. Protein Sci (2005) 0.76
Slow folding-unfolding kinetics of an octameric β-peptide bundle. ACS Chem Biol (2013) 0.75